Skip to main content
Choksi Laboratories Ltd. logo

Choksi Laboratories Ltd. — Investor Relations & Filings

Ticker · 526546 ISIN · INE493D01013 LEI · 3358009C26W7ZBKKJK66 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 7 across all filing types
Latest filing 2026-05-25 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS 526546

About Choksi Laboratories Ltd.

http://www.choksilab.com/

Choksi Laboratories Ltd. provides comprehensive analytical testing, calibration, and consultancy services. The organization specializes in chemical, microbiological, and instrumental analysis across sectors such as pharmaceuticals, food and beverages, environmental management, and chemicals. Core service offerings include environmental monitoring, water analysis, and the testing of raw materials and finished products. The company operates a network of laboratories equipped with advanced instrumentation to ensure adherence to rigorous quality standards. It maintains multiple accreditations, including NABL (ISO/IEC 17025), and holds approvals from various regulatory bodies. Beyond testing, the company offers instrument calibration and technical consultancy for laboratory infrastructure and quality management systems, supporting research, development, and regulatory compliance for its clientele.

Recent filings

Filing Released Lang Actions
1. Considered and approved Audited Financial Results for the Quarter and Financial Year ended 31st March, 2026 along with the along with the Auditors Report thereon, Statement of Assets ....
Interim / Quarterly Report Classification · 85% confidence The document is a statutory SEBI LODR Regulation 33 submission to BSE describing the “Outcome of Board Meeting” where the Directors approved audited financial results for the quarter and year ended 31 March 2026, includes the Independent Auditor’s Report and the full financial results (P&L, comprehensive income, EPS, etc.). It is not a brief earnings highlight (ER), nor a full Annual Report (10-K), nor merely an announcement (RPA). It is a comprehensive quarterly/periodic financial report containing substantive financial data as required under listing regulations. Therefore, it fits the “Interim / Quarterly Report” category (IR). FY 2026
2026-05-25 English
The clarification has been attached herewith in pursuant to additional details required for the corporate announcement filed under Regulation 30
Board/Management Information Classification · 87% confidence The document is a corporate announcement filed under SEBI (LODR) Regulation 30, detailing the resignation of the Chief Financial Officer and appointment of a new CFO, along with other board meeting resolutions. This is a clear case of a senior management change disclosure, fitting the Board/Management Information category.
2026-05-19 English
Intimation for appointment of Mrs. Stela Choksi as Chief Financial Officer of the company
Board/Management Information Classification · 98% confidence The document is a continuous disclosure under SEBI (LODR) Regulation 30 notifying the stock exchange of the board’s approval of the appointment of a new Chief Financial Officer, including her profile and related details. This is a management change announcement, not a full report or other category. Therefore, it falls under Board/Management Information (MANG).
2026-05-18 English
Intimation for resignation of Mr. Vyangesh Choksi as Chief Financial Officer of the company
Board/Management Information Classification · 89% confidence The document is a formal disclosure under SEBI Listing Regulations announcing the resignation of the company’s Chief Financial Officer (a key managerial personnel). It does not include financial data or results but rather notifies a change in senior management. This falls squarely under Board/Management Information (MANG).
2026-05-18 English
1. Considered and reviewed for purchasing of 1 MG Windsor car in the name of company along with loan facilities from HDFC bank. 2. Discussed and approved for initiating the process of ....
Board/Management Information Classification · 90% confidence The document is an outcome of a Board Meeting filed under SEBI LODR Reg. 30, detailing board decisions including appointment and resignation of the CFO and other corporate management matters. It is not a full financial report but a management change announcement. This fits the Board/Management Information category (MANG).
2026-05-18 English
Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve 1.To consider and approve ....
Regulatory Filings Classification · 85% confidence The document is a notice to the stock exchange under SEBI Listing Regulations (Regulation 29) informing of a Board meeting to consider and approve audited financial results. It does not itself contain financial results, nor is it a management change, earnings release, or proxy statement. It is a general compliance announcement submitted to the exchange, falling into the general “Regulatory Filings” category.
2026-05-16 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.